Form D · Pharmaceuticals
Vireo Health, Inc.
Minneapolis, MN · CIK 0001748349
Offering snapshot reported Aug 3, 2018 · SEC filing
- Reported sold
- $16.1M Offering amount: $17.3M
- Investors reported
- 61 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 20, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 3, 2018 | Initial | $16,093,545 | No comparison | 61 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $764K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-318444
Plus warrants to purchase shares equal to 7% of the aggregate number of shares sold pursuant to this offering.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Eight Capital Corp. | 39759 |
Source: Form D, filed Aug 3, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Stephen Dahmer | Executive |
| Eric Greenbaum | Executive |
| Aaron Hoffnung | Director, Executive |
| Kyle Kingsley | Director, Executive, Promoter |
| Amber Shimpa | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
207 South 9 Th Street
Minneapolis, MN, 55402
Minneapolis, MN, 55402